n Autoridades Comité científico revisor del documento
 

Presentación

I. Introducción


II. Objetivos

III. Situación epidemiológica de la rabia en Argentina

IV. Vigilancia epidemiológica


V. Medidas de prevención


VI. Medidas de control

VII. Tratamiento Antirrábico humano

VIII.  Métodos eutanásicos

IX. Evaluación del programa

X. Bibliografía

XI. Anexos
(planilla de remisión  de muestras, planilla de control de foco, informe mensual sobre actividades para el control de rabia)

Andrade J. Avaliação da Resposta Humoral a Quatro Esquemas de Vacinação Anti-rábica pré-exposição. Tese de Doutorado Faculdade de Medicina, UFBA, 139P., 1997.
Centers for Disease Control and Prevention. Human Rabies – Montana and Washington, 1997. MMWR, 46:770-4, 1997.
Centers for Disease Control and Prevention. Human Rabies – Texas and New Jersey, 1997. MMWR, 47:1-5, 1998.
Centers for Disease Control and Prevention. Human  Rabies Prevention-United States, 1999.
Centers for Disease Control and Prevention. Rabies Prevention – United States. Recomendatons Of The Inmunizations Practices Advisory, 1991.
Organización Internacional de Epizootias Código Zoosanitario Internacional. 2002.
Compendio Del Control de la Rabia Animal, MMWR, 1998.
Cupo, P.;Aazevedo-Marques,M..;Sarti, W. & Hering. S. - Equine Antirabies Serum Treatament During An Epizootic Outbreak In The City Of Ribeirão Preto. Brazil. Trans Roy Soc Trop Med Hyg , 92:349, 1998.
Diaz,A. M. Suckling-MouseBrain Vaccine. p. 243-50, in: Laboratory Techniques in Rabies. (Meslin,F.;  Kaplan,M . Koprowski,E.), 4TH Ed. Geneva: World Health Organization, 1996, 476P.
Evaluación del Programa Nacional de Control de Rabia en Brasil. 22 de Abril al 3 de Mayo de 2002. OPS/OMS.
Evaluación del Programa Nacional de Control de Rabia Canina en México, 18 al 28 de febrero de 2001 OPS/OMS.
Fekadu, M.; Endeshaw, T.; Wondimagegnehu, A.; Bogale, Y.; Teshager, T.; Olson, J.G. Possible Human-To-Human Transmisson of Rabies in Ethiopia. Ethiop Med J, 34:123-7, 1996.
Fitzgerald, E. A. &  Rastogi, S.C. A Collaborative Study to Stablish an International Standard Rabies Imunoglobulin  of Human Origin. J. Biol. Stan., 13: 327-33, 1985.
Fournier, P. &  Sikes, R.K. Production of Human Rabies Immunoglobulin. p. 411-6, In Laboratory Techniques in Rabies, 4TH Ed. Geneva: World Health Organization, 1996.
Fu, F.Z. Rabies and Rabies Research: Past, Present and Future. Vaccine,15 SUPPL.: S20-4, 1997.
Gode, G.R. & Bhide, N.K. Two Rabies Death After Corneal Grafts from One Donnor. Lancet, 2:791, 1988.
Guía para el Tratamiento de la Rabia en el Hombre OPS/OMS 1994.
Hatwick MA, Weiss TT, Stechschulte CJ, ET AL. Recovery From Rabies. a Case Report. ANN Intern Med. 1972;76:931-42.
Held JR, Fuenzalida E, López Adaros H, Arrosi JC, Poles N.O. Scivetti A. Inmunización Humana con Vacuna Antirrábica de Cerebro Ratón Lactante. Bol. Ofic. Sanit. Panamer.; 1972;72:565-75.
Helmick CG. The Epidemiology of Human Fabies Portexposture Prophylaxis, 1980-1981. JAMA. 1983; 250:1990-6.
Helmick, C.G.; Fauxe, R.V.; Vernon, A. Iis There a Risk to Contacts of Pacients with Rabies? Rev  Infect Dis, 9:511-8, 1987.
Hemachudha T, Phanupahk P. Sriwanthana B, Et Al. Immunologic Study of Human Encephalitic and Paralytic Rabies. Preliminary Report of 16 Pacients. Am J Med 1988; 84: 673-7.
Lang, J. & Plotkin, S. Rabies Risk and Immunoprophylaxis in Children. p. 219-53, Advances in Pediatric Infeccious Disease, vol 13 ;Mosby-Year Book, Inc; 1998.
Lontai,  I. The Current State of Rabies Prevention in Europe. Vaccine, 15 Suppl.: S 16-9, 1997.
Lumio J, Hillbom M, Roine R, et al. Human Rabies of Bat Origen in Europe (letter). Llancet. 1986;1:378.
Mackenzie, J. S. Emerging Viral Diseases: an Australian Perspective. Emerg Infect Dis, 5:1-8, 1999.
Montagnon, B. & Fanget, B. Purified Vero Cell Vaccine for Humans. p. 285-96, 4th Ed. Geneva: World Health Organization, 1996, 476p.
Mortiere, M.D. & Falcone, A.L. an Acute Neurologic Syndrome Temporally Associated with Posexposure Treatment of Rabies. Pediatrics , 100:720-1, 1997.
Murphy F, Morphology and Morphogenesis. The Natural History of Rabies New York: Academic Press; 33 – 61,1975.
Murphy F A. Rabies Pathogenesis; a Bried Review. Arch. Virol. 54:279-297; 1977.
Organización Panamericana de la Salud. El Control de las Enfermedades Transmisibles en el Hombre", Washington, USA 1992.
Pereira, O. A.  Coutinho, N.; Raphaelian, T.; Godano,  A. Anti-rabies Revaccination in Humans. Rev Microbiol , 2 (2): 83-6, 1971.
Plotkin, S. A.; Rupprecht, C.E.; Koprowski, H. RabiesVaccine. p.743-66, in: Vaccines (Plotkin, S.A. & Orenstein, W.A.), 3rd Ed. Philadelphia: Wb Saunders Company, 1999.
Tordo, N. Characteristics and Molecular Biology of the Rabies Virus. p. 28-51, in: Laboratory Techniques in Rabies., 4th Ed. Geneva: World Health Organization, 1996, 476p.
Vigilancia Epidemiológica de la Rabia en las Américas 2000-2001 OPS/OMS.
Warell D A, Warrell M J. Human Rabies and Its Prevention: An Overview. Rev Infect Dis. 1988; 10 (Suppl 4): s726-31.
Warrell D A. The Clinical Picture of Rabies in Man Trans R Soc Trop Med Hyg. 1976;70:188-95.
Who Expert Committee on Rabies, 8th Report. Geneve: World Health Organization, 1992 (Who Tecnical Report Series, No. 824).
Who World Survey of Rabies No 34, for the year 1998. Geneva. World Health Organization 2000.
Who. Recommendations on Rabies Post-exposure Treatment and the Correct Thecnique of Intradermal Immunization Against Rabies.Geneva: World Health Organization, 1997.
Who Report of a Who Consultation on Intradermal Application of Human Rabies Vaccines;March 13-14 1995; Geneva: World Health Organization, 1995.
Wilde, H. Postexposure Rabies Treatment: View from Southeast Asia. Abstracts of The International Rabies Meeting ;Institut Pasteur, Paris; march 13-14, 1997. p. 6.01. 1997
Wilde, H. Rabies, 1996. Intern.JInfect. Dis., 1:135-42, 1997.
Winkler W G, Fashinell T, Leffingwell L, et al. Airborne Rabies Transmission in a Laboratory Worker.Jama. ; 266: 1219 - 21. 1973.
Who Weekly epidemiological record; February 23 2007; Nº 8, 82 61-68.
Díaz,A.M.O.; González Rescigno,G.; Fernández Munilla;A.; Larghi, O.P.; Marchevsky, N.; Arrossi, J.C.. Vacuna antirrábica  de cerebro de ratón lactante. Esquemas reducidos de inmunización post-exposición. Rev.Arg.Microbiol.1979 11; 42-44.
Held,J.R.; Fuenzalida, E.; López Adaros, H.; Arrossi, J.C.; Poles, N.O.R.; Scivetti, A. Inmunización Humana con vacuna antirrábica de cerebro de ratón lactante. Bol. Ofic.Panamer.; 1972; 72: 565-575.
Fuenzalida, E. Human pre-exposure rabies inmunization with suckling mouse brain vaccine. Bull.Wld.Htlth.Org. 1972; 46:561-563.
Ley de Profilaxis de la Rabia de la Pcia. de Bs.As. 8056/73 y Decr.Regl.
Ley Nacional. 24.836/97.
Comisión Técnica Asesora M. Salud Pcia. Bs.As. Tenencia Responsable de los Animales (documento, 1994)
Normas Técnicas para la atención de personas mordidas y tratamiento eventivo de la rabia. Ministerio de Salud Pcia. Bs.As. 1988.
Guía para el tratamiento de la rabia en el hombre. OPS-OMS.1994. Publicación técnica n°2.
Programa Provincial de Control de Rabia, Ministerio de Salud, provincia de Buenos Aires.